Record
Loading…
Record
Loading…
organization
Gilead Sciences is an American biopharmaceutical company, headquartered in Foster City. It reported revenue of $29.44B for the period ended .
| fact | value | valid from | conf | sources |
|---|---|---|---|---|
| quarterly net income | 2,429,000,000 United States dollar | primary, 1 source for quarterly net income | ||
| quarterly operating income | 3,462,000,000 United States dollar | primary, 1 source for quarterly operating income | ||
| quarterly research and development | 1,101,000,000 United States dollar | primary, 1 source for quarterly research and development | ||
| quarterly revenue | 8,300,000,000 United States dollar | primary, 1 source for quarterly revenue | ||
| research and development | 9,106,000,000 United States dollar | primary, 1 source for research and development | ||
| shares outstanding | 1,240,338,614 shares | primary, 1 source for shares outstanding | ||
| total equity | 13,040,000,000 United States dollar | primary, 1 source for total equity |
No dated events on the record yet.
Every claim on the timeline, including undated ones →